NO301548B1 - Fremgangsmåte for mikrobiell bioomdannelse av en utvalgt fenylforbindelse, samt mikroorganismevertsceller, rekombinante plasmider og DNA-segment - Google Patents
Fremgangsmåte for mikrobiell bioomdannelse av en utvalgt fenylforbindelse, samt mikroorganismevertsceller, rekombinante plasmider og DNA-segment Download PDFInfo
- Publication number
- NO301548B1 NO301548B1 NO894845A NO894845A NO301548B1 NO 301548 B1 NO301548 B1 NO 301548B1 NO 894845 A NO894845 A NO 894845A NO 894845 A NO894845 A NO 894845A NO 301548 B1 NO301548 B1 NO 301548B1
- Authority
- NO
- Norway
- Prior art keywords
- recombinant plasmid
- microorganism host
- host cell
- toluene
- fragment
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title claims description 104
- 244000005700 microbiome Species 0.000 title claims description 46
- 238000000034 method Methods 0.000 title claims description 29
- -1 Phenyl Compound Chemical class 0.000 title claims description 8
- 230000000813 microbial effect Effects 0.000 title claims description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 303
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 61
- 239000012634 fragment Substances 0.000 claims description 44
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 claims description 26
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 23
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 20
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 claims description 13
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 10
- 241000589755 Pseudomonas mendocina Species 0.000 claims description 10
- 229940097275 indigo Drugs 0.000 claims description 10
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 10
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 10
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 10
- 239000013600 plasmid vector Substances 0.000 claims description 9
- 150000002989 phenols Chemical class 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 4
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 238000005805 hydroxylation reaction Methods 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000033444 hydroxylation Effects 0.000 claims description 3
- OFJWFSNDPCAWDK-UHFFFAOYSA-N 2-phenylbutyric acid Chemical compound CCC(C(O)=O)C1=CC=CC=C1 OFJWFSNDPCAWDK-UHFFFAOYSA-N 0.000 claims description 2
- 229960001413 acetanilide Drugs 0.000 claims description 2
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 91
- 108020004414 DNA Proteins 0.000 description 40
- 238000006243 chemical reaction Methods 0.000 description 29
- 108090000623 proteins and genes Proteins 0.000 description 25
- 230000037361 pathway Effects 0.000 description 22
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 230000009466 transformation Effects 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 238000010276 construction Methods 0.000 description 10
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 10
- 241001131785 Escherichia coli HB101 Species 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 8
- 230000021615 conjugation Effects 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 239000004098 Tetracycline Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229960002180 tetracycline Drugs 0.000 description 6
- 229930101283 tetracycline Natural products 0.000 description 6
- 235000019364 tetracycline Nutrition 0.000 description 6
- 150000003522 tetracyclines Chemical class 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 101150057066 nahG gene Proteins 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 241000589516 Pseudomonas Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000036983 biotransformation Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- FWZBPBKAANKOJQ-UHFFFAOYSA-N 2-[4-(hydroxymethyl)phenyl]acetic acid Chemical group OCC1=CC=C(CC(O)=O)C=C1 FWZBPBKAANKOJQ-UHFFFAOYSA-N 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 230000006652 catabolic pathway Effects 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- PGSWEKYNAOWQDF-UHFFFAOYSA-N 3-methylcatechol Chemical compound CC1=CC=CC(O)=C1O PGSWEKYNAOWQDF-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 206010007733 Catabolic state Diseases 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
- 241000276498 Pollachius virens Species 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 101100186375 Pseudomonas putida nahR gene Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000003169 complementation method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 101150027505 nahR gene Proteins 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005817 monooxygenase reaction Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000003385 ring cleavage reaction Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/08—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
- C12P7/12—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing sulfite waste liquor or citrus waste
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/177,631 US5017495A (en) | 1988-04-05 | 1988-04-05 | Plasmid encoding the Pseudomonas mendocina toluene monooxygenase gene |
PCT/US1989/001445 WO1989009828A1 (en) | 1988-04-05 | 1989-04-04 | Method and materials for the microbial bioconversion of toluene and other phenyl compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO894845D0 NO894845D0 (no) | 1989-12-04 |
NO894845L NO894845L (no) | 1990-02-02 |
NO301548B1 true NO301548B1 (no) | 1997-11-10 |
Family
ID=22649341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO894845A NO301548B1 (no) | 1988-04-05 | 1989-12-04 | Fremgangsmåte for mikrobiell bioomdannelse av en utvalgt fenylforbindelse, samt mikroorganismevertsceller, rekombinante plasmider og DNA-segment |
Country Status (12)
Country | Link |
---|---|
US (1) | US5017495A (ja) |
EP (1) | EP0336719A3 (ja) |
JP (1) | JP2862301B2 (ja) |
KR (1) | KR0157301B1 (ja) |
AU (1) | AU625220B2 (ja) |
CA (1) | CA1337977C (ja) |
DK (1) | DK175789B1 (ja) |
FI (1) | FI104379B (ja) |
IL (1) | IL89845A (ja) |
NO (1) | NO301548B1 (ja) |
WO (1) | WO1989009828A1 (ja) |
ZA (1) | ZA892503B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5171684A (en) * | 1988-04-05 | 1992-12-15 | Amgen Inc. | Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1 |
CA2069741C (en) * | 1990-09-28 | 1996-06-18 | Kwang-Mu Yen | Cloning cartridges and expression vectors in gram-negative bacteria |
US6642031B2 (en) | 1995-11-20 | 2003-11-04 | Genencor International, Inc. | Microorganisms with ability to degrade indole and enzymes therefrom |
US6190892B1 (en) * | 1995-11-20 | 2001-02-20 | Genencor International, Inc. | Microbial production of indigo |
US5958757A (en) * | 1996-09-13 | 1999-09-28 | Envirogen, Inc. | Biological conversion of organic compounds |
DK0932662T3 (da) * | 1996-09-25 | 2008-03-03 | Genencor Int | Mikroorganismer med evnen til at nedbryde indol og ekstrakter deraf med indoloxidase-aktivitet |
US6395539B1 (en) | 1997-05-05 | 2002-05-28 | Ohio University | Composition and methods for bioremediation |
US6551814B1 (en) | 1997-05-05 | 2003-04-22 | Ohio University | Methods for bioremediation by degrading toluene |
US6830899B1 (en) | 1997-06-13 | 2004-12-14 | E. I. Du Pont De Nemours And Company | Method for the production of para-hydroxybenzoate in Pseudomonas mendocina |
WO1999023224A1 (en) * | 1997-10-31 | 1999-05-14 | E.I. Du Pont De Nemours And Company | A GENE ENCODING A PUTATIVE EFFLUX PROTEIN FOR SOLVENTS/ANTIBIOTICS IN $i(PSEUDOMONAS MENDOCINA) |
AU1133900A (en) | 1998-10-26 | 2000-07-12 | University Of Iowa Research Foundation, The | Novel naphthalene dioxygenase and methods for their use |
US6586229B1 (en) * | 2000-06-01 | 2003-07-01 | North Carolina State University | Method for the production of ρ-Hydroxybenzoate in species of pseudomonas and agrobacterium |
WO2002006452A2 (en) * | 2000-07-18 | 2002-01-24 | National Research Council Of Canada | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1436573A (en) * | 1972-06-07 | 1976-05-19 | Gen Electric | Microorganisms |
US4477570A (en) * | 1981-09-24 | 1984-10-16 | Occidental Chemical Corporation | Microbial degradation of obnoxious organic wastes into innocucous materials |
JPS59501732A (ja) * | 1982-09-20 | 1984-10-18 | アムジエン | 芳香族炭化水素類の微生物学的酸化のための方法および材料 |
US4520103A (en) * | 1982-10-27 | 1985-05-28 | Amgen | Microbial production of indigo |
US4959315A (en) * | 1987-04-30 | 1990-09-25 | The United States Of America As Represented By The Administrator Of The Environmental Protection Agency | Biodegradation of chloroethylene compounds |
-
1988
- 1988-04-05 US US07/177,631 patent/US5017495A/en not_active Expired - Lifetime
-
1989
- 1989-04-03 CA CA000595484A patent/CA1337977C/en not_active Expired - Fee Related
- 1989-04-04 KR KR1019890702299A patent/KR0157301B1/ko not_active IP Right Cessation
- 1989-04-04 AU AU34104/89A patent/AU625220B2/en not_active Expired
- 1989-04-04 WO PCT/US1989/001445 patent/WO1989009828A1/en active IP Right Grant
- 1989-04-04 EP EP89303329A patent/EP0336719A3/en not_active Withdrawn
- 1989-04-04 JP JP1504385A patent/JP2862301B2/ja not_active Expired - Lifetime
- 1989-04-04 IL IL8984589A patent/IL89845A/en unknown
- 1989-04-05 ZA ZA892503A patent/ZA892503B/xx unknown
- 1989-12-04 FI FI895788A patent/FI104379B/fi not_active IP Right Cessation
- 1989-12-04 NO NO894845A patent/NO301548B1/no not_active IP Right Cessation
- 1989-12-04 DK DK198906090A patent/DK175789B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL89845A0 (en) | 1989-12-15 |
FI895788A0 (fi) | 1989-12-04 |
US5017495A (en) | 1991-05-21 |
KR900700612A (ko) | 1990-08-16 |
IL89845A (en) | 1994-11-28 |
DK175789B1 (da) | 2005-02-21 |
WO1989009828A1 (en) | 1989-10-19 |
EP0336719A2 (en) | 1989-10-11 |
DK609089A (da) | 1990-01-24 |
JPH03500126A (ja) | 1991-01-17 |
NO894845L (no) | 1990-02-02 |
CA1337977C (en) | 1996-01-23 |
AU3410489A (en) | 1989-11-03 |
ZA892503B (en) | 1991-12-24 |
JP2862301B2 (ja) | 1999-03-03 |
KR0157301B1 (ko) | 1998-10-15 |
EP0336719A3 (en) | 1989-11-15 |
NO894845D0 (no) | 1989-12-04 |
AU625220B2 (en) | 1992-07-02 |
FI104379B (fi) | 2000-01-14 |
DK609089D0 (da) | 1989-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chaudhry et al. | Isolation and characterization of a new plasmid from a Flavobacterium sp. which carries the genes for degradation of 2, 4-dichlorophenoxyacetate | |
Jeon et al. | The naphthalene catabolic (nag) genes of Polaromonas naphthalenivorans CJ2: evolutionary implications for two gene clusters and novel regulatory control | |
Egland et al. | Benzoate-coenzyme A ligase, encoded by badA, is one of three ligases able to catalyze benzoyl-coenzyme A formation during anaerobic growth of Rhodopseudomonas palustris on benzoate | |
Zylstra et al. | Toluene degradation by Pseudomonas putida F1: genetic organization of the tod operon | |
Carreno-Lopez et al. | Physiological evidence for differently regulated tryptophan-dependent pathways for indole-3-acetic acid synthesis in Azospirillum brasilense | |
Gescher et al. | Genes coding for a new pathway of aerobic benzoate metabolism in Azoarcus evansii | |
Ahmad et al. | Cloning and expression of genes involved in 4-chlorobiphenyl transformation by Pseudomonas testosteroni: homology to polychlorobiphenyl-degrading genes in other bacteria | |
US20040267001A1 (en) | Genes encoding baeyer-villiger monooxygenases | |
NO301548B1 (no) | Fremgangsmåte for mikrobiell bioomdannelse av en utvalgt fenylforbindelse, samt mikroorganismevertsceller, rekombinante plasmider og DNA-segment | |
Jones et al. | sal genes determining the catabolism of salicylate esters are part of a supraoperonic cluster of catabolic genes in Acinetobacter sp. strain ADP1 | |
Benson et al. | Plasmid-determined alcohol dehydrogenase activity in alkane-utilizing strains of Pseudomonas putida | |
Kivisaar et al. | Degradation of phenol and m-toluate in Pseudomonas sp. strain EST1001 and its Pseudomonas putida transconjugants is determined by a multiplasmid system | |
EP0504349B1 (en) | BIOCONVERSIONS CATALYZED BY THE TOLUENE MONOOXYGENASE OF $i(PSEUDOMONAS MENDOCINA) KR-1 | |
Winstanley et al. | pWW174: A large plasmid from Acinetobacter calcoaceticus encoding benzene catabolism by the β‐ketoadipate pathway | |
IE83308B1 (en) | Bioconversions catalyzed by the toluene monooxygenase of pseudomonas mendocina KR-1 | |
Parke et al. | Toxicity caused by hydroxycinnamoyl-coenzyme A thioester accumulation in mutants of Acinetobacter sp. strain ADP1 | |
Grabau et al. | A Salmonella typhimurium cobalamin-deficient mutant blocked in 1-amino-2-propanol synthesis | |
Stephens et al. | Cloning and expression in Escherichia coli of the toluene dioxygenase gene from Pseudomonas putida NCIB11767 | |
US5605823A (en) | Bioconversions catalysed by the toluene monooxygenase of Pseudomonas mendocinaKR-1 | |
Altenschmidt et al. | Evidence that enzymes of a novel aerobic 2‐amino‐benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid | |
Maseda et al. | Development of expression vectors for Thermus thermophilus | |
Thipayathasana | Isolation and properties of Escherichia coli ATPase mutants with altered divalent metal specificity for ATP hydrolysis | |
Kiesel et al. | The meta pathway as a potential energy‐generating sequence and its effects on the growth rate during the utilisation of aromatics | |
Dutton et al. | Comamonas acidovorans UCC61 catabolizes o-phthalate via a 4, 5-oxygenation pathway that is encoded on a 70 kbp section of plasmid pOPH1 bounded by directly repeated sequences | |
Shapiro et al. | Perspectives for genetic engineering of hydrocarbon oxidizing bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |